Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 2
1962 3
1963 1
1966 1
1967 2
1995 1
1996 3
1997 2
2000 2
2002 5
2003 15
2004 7
2005 13
2006 6
2007 9
2008 10
2009 11
2010 11
2011 11
2012 15
2013 17
2014 16
2015 16
2016 37
2017 23
2018 24
2019 39
2020 45
2021 30
2022 17
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

385 results

Results by year

Filters applied: . Clear all
Page 1
Dengue.
Wilder-Smith A, Ooi EE, Horstick O, Wills B. Wilder-Smith A, et al. Lancet. 2019 Jan 26;393(10169):350-363. doi: 10.1016/S0140-6736(18)32560-1. Lancet. 2019. PMID: 30696575 Review.
Dengue vaccine development: status and future.
Wilder-Smith A. Wilder-Smith A. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):40-44. doi: 10.1007/s00103-019-03060-3. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 31784763 Free PMC article. Review.
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O'Brien KL, Smith PG, Wilder-Smith A, Zeger S, Deloria Knoll M, Patel MK. Feikin DR, et al. Among authors: wilder smith a. Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23. Lancet. 2022. PMID: 35202601 Free PMC article.
Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
Wilder-Smith A, Mulholland K. Wilder-Smith A, et al. N Engl J Med. 2021 Sep 2;385(10):946-948. doi: 10.1056/NEJMe2111165. N Engl J Med. 2021. PMID: 34469651 Free PMC article. No abstract available.
Editorial overview: The challenge to defeat dengue.
Hiscott J, Wilder-Smith A. Hiscott J, et al. Among authors: wilder smith a. Curr Opin Virol. 2020 Aug;43:iii-v. doi: 10.1016/j.coviro.2020.10.004. Curr Opin Virol. 2020. PMID: 33160602 No abstract available.
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.
Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C, Selemon A, Whelan M, Premji Z, Issa H, Cheng B, Abu Raddad LJ, Buckeridge DL, Van Kerkhove MD, Piechotta V, Higdon MM, Wilder-Smith A, Bergeri I, Feikin DR, Arora RK, Patel MK, Subissi L. Bobrovitz N, et al. Among authors: wilder smith a. Lancet Infect Dis. 2023 May;23(5):556-567. doi: 10.1016/S1473-3099(22)00801-5. Epub 2023 Jan 18. Lancet Infect Dis. 2023. PMID: 36681084 Free PMC article.
An update on Zika vaccine developments.
Durbin A, Wilder-Smith A. Durbin A, et al. Among authors: wilder smith a. Expert Rev Vaccines. 2017 Aug;16(8):781-787. doi: 10.1080/14760584.2017.1345309. Expert Rev Vaccines. 2017. PMID: 28633549 Review.
Yellow Fever in Travelers.
Wilder-Smith A. Wilder-Smith A. Curr Infect Dis Rep. 2019 Oct 31;21(11):42. doi: 10.1007/s11908-019-0701-x. Curr Infect Dis Rep. 2019. PMID: 31673899 Review.
Clinical Pearls in travellers and migrants.
Wilder-Smith A, van Genderen PJ, Barkati S, Coyle C, Staehelin C, Richter J, Bottieau E. Wilder-Smith A, et al. J Travel Med. 2019 Jan 1;26(1). doi: 10.1093/jtm/tay147. J Travel Med. 2019. PMID: 30535197 No abstract available.
385 results